Description
Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg
Free from every infection
- The broad spectrum of antibacterial activity
- Greater in vitro activity against S.pneumoniae than Cefaclor, Cefuroxime, Cefprozil or Cefixime
- 0nce daily as effective as thrice daily Cefaclor or twice daily Co-amoxiclav
Indicated in
- Upper respiratory tract infections
- Acute exacerbations of chr0nic br0nchitis
- Acute community-acquired pneumonia
Reviews
There are no reviews yet.